Bronchiectasis clinical trials

The registry lists 404 studies for Bronchiectasis across more than 10 countries. 125 are recruiting or about to start. 297 of them are mainly about Bronchiectasis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its narrower condition Kartagener Syndrome too: 425 studies, 129 open.

Get an email when these change. Save the Bronchiectasis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 163
Recruiting: 93
Status unknown: 71
Not yet recruiting: 28
Terminated: 25
Active, not recruiting: 14

Phase

Phase 2: 48
Phase 4: 37
Phase 3: 35
Phase 1: 26
Early Phase 1: 2

Where

China: 84
United Kingdom: 73
United States: 65
Spain: 39
Turkey: 35
Italy: 30

Who runs them

Shanghai Pulmonary Hospital, Shanghai, China (17) · Assiut University (17) · Haisco Pharmaceutical Group Co., Ltd. (7) · Guangzhou Institute of Respiratory Disease (7) · The First Affiliated Hospital of Guangzhou Medical University (6) · Hacettepe University (6) · Ruijin Hospital (6) · Boehringer Ingelheim (6)

What is being tested here

Drugs under test in Bronchiectasis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Azithromycin	2	3	8
Verducatib	2	2	5
Florensocatib	2	1	2
Itraconazole	2	1	2
Cholecalciferol	1	0	2
Ceftolozane	1	0	1
GSK3862995B	1	0	1
Albuterol	1	0	1
Tobramycin	0	1	5
Ciprofloxacin	0	2	4

Drug classes tested here Bronchodilators 2 open

Coming up

9phase 3 studies under way

51studies finish main data collection within a year5 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Nov 2026A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis · Phase 3 · Haisco Pharmaceutical Group Co., Ltd.
Dec 2026Long-Term Safety and Efficacy of Moxifloxacin in Bronchiectasis Patients · Phase 3 · Assiut University
Feb 2027Benefits of Inhalation of Hypertonic Saline Solution Prior to Physiotherapy ELTGOL Technique in Bronchiectasis · Phase 3 · Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Mar 2027Enhancing Lung Health in Kids With Structural Lung Damage and Malformations: Azithromycin (AZI) for Airway Infection Prevention · Phase 3 · Rigshospitalet, Denmark
Jun 2027The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis · Phase 3 · Boehringer Ingelheim
Nov 2026Phase 1 Study to Assess the Effects of HSK31858 on the QT/QTc Interval in Healthy Chinese Participants · Haisco Pharmaceutical Group Co., Ltd.
Nov 2026Investigation of Pharmacokinetics, Safety of HSK31858 in Subjects With Renal Impairment · Haisco Pharmaceutical Group Co., Ltd.
Nov 2026HFNC in Management of Bronchiectasis Exacerbation · Assiut University
Nov 2026Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases · Assiut University
Nov 2026Bronchiectasis Phenotype Identification Model · Assiut University

Who these studies take

Of the 93 Bronchiectasis studies recruiting now, 50 (54%) set no upper age limit and 13 (14%) stop at 75 or younger. 12 (13%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 26 (28%) take healthy volunteers.

Recruiting studies that take each age, of 93
Age	Women	Men
10	9 (10%)	9 (10%)
18	84 (90%)	84 (90%)
30	87 (94%)	87 (94%)
40	89 (96%)	89 (96%)
50	88 (95%)	88 (95%)
65	87 (94%)	87 (94%)
75	81 (87%)	81 (87%)
85	68 (73%)	68 (73%)

Across all 404 studies, recruiting or not: 23% stop at 75 or younger and 15% at 65; 15% take children; <1% are for women only and 0% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Bronchiectasis studies take

Of 24 phase 2 interventional studies under Bronchiectasis, half reached primary completion within 24 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Phase 2	24 mo15–32 · 24 studies	—	—
Interventional, no phase	20 mo10–59 · 78 studies	—	20 mo10–67 · 72 studies
Observational	34 mo12–… · 62 studies	—	—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting1

THERMotherapy Against Persistent Bacterial LUNG InfectionsNov 6, 2026NCT05351242

Stopped1

Sjogren's Lung StudyTerminatedNov 9, 2026NCT04843345

Newly registered3

Chronic Respiratory Disease Participant Engagement StudyNov 9, 2026NCT07924462
A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Nov 4, 2026NCT07915219
Diagnostic Value of Oropharyngeal Suction and Effect of Respiratory Physiotherapy on the Detection of Microorganisms in the Pediatric PatientOct 29, 2026NCT07903792

Studies

Recruiting first, then most recently updated. Showing 50 of 404. Browse all 404 → or search them.